Breaking News, Collaborations & Alliances

Wheeler Bio to Support MindImmune’s Alzheimer’s Prevention Program

Wheeler Bio will provide integrated process development and cGMP drug substance manufacturing services.

Wheeler Bio, a U.S.-based contract development and biomanufacturing organization (CDMO), has entered into an agreement with MindImmune Therapeutics, a biopharmaceutical company focused on neuroinflammation and Alzheimer’s disease.  Under the agreement, Wheeler Bio will provide integrated process development and cGMP drug substance manufacturing services via its ModularCMC platform specializing in antibody-based modalities to support the advancement of the MITI-101 program, MindImmune&#8...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters